PMH36 A COST-UTILTY ANALYSIS OF ATOMOXETINE AGAINST CURRENT STIMULANT THERAPIES FOR THE TREATMENT OF CHILDREN WITH ATTENTION DEFICIT/HYPERACTIVITY DISORDER (ADHD) IN GERMANY
Nov 1, 2007, 00:00
10.1016/S1098-3015(10)65086-3
https://www.valueinhealthjournal.com/article/S1098-3015(10)65086-3/fulltext
Title :
PMH36 A COST-UTILTY ANALYSIS OF ATOMOXETINE AGAINST CURRENT STIMULANT THERAPIES FOR THE TREATMENT OF CHILDREN WITH ATTENTION DEFICIT/HYPERACTIVITY DISORDER (ADHD) IN GERMANY
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)65086-3&doi=10.1016/S1098-3015(10)65086-3
First page :
Section Title :
Open access? :
No
Section Order :
245